SAO PAULO (Reuters) – The National Health Surveillance Agency (Anvisa) on Saturday determined the precautionary ban on batches of Chinese vaccine against Covid-19 CoronaVac, prohibiting the distribution and use of batches in a plant not approved in the emergency use authorization , said the regulator in a statement.
According to the statement, Anvisa was informed the day before by the Butantan Institute that Sinovac, the manufacturer of CoronaVac, sent to Brazil 25 batches in the vial-ampoule presentation (single dose and two doses), totaling 12,113,934 doses.
Read Also
- Twitter: Why Elon Musk’s massive layoffs are worrying the European Union Nov 25, 2022
- La Voz Senior Perú 2021 LIVE premiere on Internet TV Frequency: follow the blind auditions, judges, what time it opens, channel Aug 28, 2021
- What is the ‘right to repair’, the movement that could save you thousands of pesos with your iPhone Sep 3, 2021
- Boric explains why Reform does not touch pensions of the Armed Forces: “You have to know how to choose the battles” Nov 8, 2022
- Côtes-d’Armor: Irritated after a first collision, he hits the car again Nov 16, 2022
- Presidential spokesman says the electrical system is returning to normal throughout the country May 21, 2022
- Milan, Giroud is coming. Then fantasy for Pioli: hunting for ten Jul 10, 2021